Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP805966.RACvSNaJ-S_MUM_VIDr2hNoTbyyz6VZxfemUt_iMEL8DY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP805966.RACvSNaJ-S_MUM_VIDr2hNoTbyyz6VZxfemUt_iMEL8DY130_assertion type Assertion NP805966.RACvSNaJ-S_MUM_VIDr2hNoTbyyz6VZxfemUt_iMEL8DY130_head.
- NP805966.RACvSNaJ-S_MUM_VIDr2hNoTbyyz6VZxfemUt_iMEL8DY130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805966.RACvSNaJ-S_MUM_VIDr2hNoTbyyz6VZxfemUt_iMEL8DY130_provenance.
- NP805966.RACvSNaJ-S_MUM_VIDr2hNoTbyyz6VZxfemUt_iMEL8DY130_assertion evidence source_evidence_literature NP805966.RACvSNaJ-S_MUM_VIDr2hNoTbyyz6VZxfemUt_iMEL8DY130_provenance.
- NP805966.RACvSNaJ-S_MUM_VIDr2hNoTbyyz6VZxfemUt_iMEL8DY130_assertion SIO_000772 20389136 NP805966.RACvSNaJ-S_MUM_VIDr2hNoTbyyz6VZxfemUt_iMEL8DY130_provenance.
- NP805966.RACvSNaJ-S_MUM_VIDr2hNoTbyyz6VZxfemUt_iMEL8DY130_assertion wasDerivedFrom befree-2016 NP805966.RACvSNaJ-S_MUM_VIDr2hNoTbyyz6VZxfemUt_iMEL8DY130_provenance.
- NP805966.RACvSNaJ-S_MUM_VIDr2hNoTbyyz6VZxfemUt_iMEL8DY130_assertion wasGeneratedBy ECO_0000203 NP805966.RACvSNaJ-S_MUM_VIDr2hNoTbyyz6VZxfemUt_iMEL8DY130_provenance.